Efficacy and safety of adalimumab by intra-articular injection for moderate to severe knee osteoarthritis: An open-label randomized controlled trial
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Efficacy and safety of adalimumab by intra-articular injection for moderate to severe knee osteoarthritis: An open-label randomized controlled trial
Authors
Keywords
-
Journal
JOURNAL OF INTERNATIONAL MEDICAL RESEARCH
Volume 46, Issue 1, Pages 326-334
Publisher
SAGE Publications
Online
2017-08-25
DOI
10.1177/0300060517723182
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The impact of disease activity and tumour necrosis factor-α inhibitor therapy on cytokine levels in juvenile idiopathic arthritis
- (2016) H. M. Walters et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- RETRACTED: Effectiveness of non-steroidal anti-inflammatory drugs for the treatment of pain in knee and hip osteoarthritis: a network meta-analysis
- (2016) Bruno R da Costa et al. LANCET
- Nerve Growth Factor Regulation by TNF-αand IL-1βin Synovial Macrophages and Fibroblasts in Osteoarthritic Mice
- (2016) Shotaro Takano et al. Journal of Immunology Research
- Comparative Effectiveness of Pharmacologic Interventions for Knee Osteoarthritis
- (2015) Raveendhara R. Bannuru et al. ANNALS OF INTERNAL MEDICINE
- A psychometric analysis of outcome measures in peripheral spondyloarthritis
- (2015) Maureen C Turina et al. ANNALS OF THE RHEUMATIC DISEASES
- Protective effects of tumor necrosis factor-α blockade by adalimumab on articular cartilage and subchondral bone in a rat model of osteoarthritis
- (2015) C.H. Ma et al. BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH
- Commentary on recent therapeutic guidelines for osteoarthritis
- (2015) Maurizio Cutolo et al. SEMINARS IN ARTHRITIS AND RHEUMATISM
- Efficacy of Direct Injection of Etanercept into Knee Joints for Pain in Moderate and Severe Knee Osteoarthritis
- (2015) Seiji Ohtori et al. YONSEI MEDICAL JOURNAL
- Progranulin protects against osteoarthritis through interacting with TNF-α and β-Catenin signalling
- (2014) Yun-peng Zhao et al. ANNALS OF THE RHEUMATIC DISEASES
- Analysis of local and systemic TNF-α and IL1-α expression in the acute phase of knee osteoarthritis of rats
- (2014) Carolina Náglio Kalil Dias et al. CYTOKINE
- Comparative efficacy of biologics as monotherapy and in combination with methotrexate on patient reported outcomes (PROs) in rheumatoid arthritis patients with an inadequate response to conventional DMARDs – a systematic review and network meta-analysis
- (2014) Jeroen P Jansen et al. Health and Quality of Life Outcomes
- Health economics in the field of osteoarthritis: An Expert's consensus paper from the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO)
- (2013) Mickaël Hiligsmann et al. SEMINARS IN ARTHRITIS AND RHEUMATISM
- Osteoarthritis: A disease of the joint as an organ
- (2012) Richard F. Loeser et al. ARTHRITIS AND RHEUMATISM
- Discordance between pain and radiographic severity in knee osteoarthritis: Findings from quantitative sensory testing of central sensitization
- (2012) Patrick H. Finan et al. ARTHRITIS AND RHEUMATISM
- Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010
- (2012) Christopher J L Murray et al. LANCET
- Targeting tumour necrosis factor alleviates signs and symptoms of inflammatory osteoarthritis of the knee
- (2012) Walter P Maksymowych et al. ARTHRITIS RESEARCH & THERAPY
- Neuropathic pain symptoms in a community knee OA cohort
- (2011) J.R. Hochman et al. OSTEOARTHRITIS AND CARTILAGE
- Role of proinflammatory cytokines in the pathophysiology of osteoarthritis
- (2010) Mohit Kapoor et al. Nature Reviews Rheumatology
- Tanezumab for the Treatment of Pain from Osteoarthritis of the Knee
- (2010) Nancy E. Lane et al. NEW ENGLAND JOURNAL OF MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started